ChemicalBook > CAS DataBase List > LOXIGLUMIDE

LOXIGLUMIDE

Product Name
LOXIGLUMIDE
CAS No.
107097-80-3
Chemical Name
LOXIGLUMIDE
Synonyms
CS-162;cr1505;anoicacid;(+-)--5-oxo;LOXIGLUMIDE;ntanoicacid;Loxiglumide, >98%;LoxigluMide (CR1505);Loxiglumide >=97% (HPLC);(+-)-4-((3,4-dichlorobenzoyl)amino)-5-((3-methoxypropyl)pentylamino)-5-oxope
CBNumber
CB0326090
Molecular Formula
C21H30Cl2N2O5
Formula Weight
461.38
MOL File
107097-80-3.mol
More
Less

LOXIGLUMIDE Property

Melting point:
113-115℃
Boiling point:
632.2±55.0 °C(Predicted)
Density 
1.233±0.06 g/cm3(Predicted)
storage temp. 
2-8°C
solubility 
DMSO: ≥5mg/mL
pka
pKa ~5(at 25℃)
form 
powder
color 
white to beige
CAS DataBase Reference
107097-80-3
More
Less

Safety

Hazard Codes 
Xn
Risk Statements 
22
WGK Germany 
3
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
SML0130
Product name
Loxiglumide
Purity
≥97% (HPLC)
Packaging
10mg
Price
$96.1
Updated
2024/03/01
Sigma-Aldrich
Product number
SML0130
Product name
Loxiglumide
Purity
≥97% (HPLC)
Packaging
50mg
Price
$313
Updated
2024/03/01
Cayman Chemical
Product number
25534
Product name
Loxiglumide
Purity
≥98%
Packaging
5mg
Price
$56
Updated
2024/03/01
Cayman Chemical
Product number
25534
Product name
Loxiglumide
Purity
≥98%
Packaging
10mg
Price
$87
Updated
2024/03/01
Cayman Chemical
Product number
25534
Product name
Loxiglumide
Purity
≥98%
Packaging
25mg
Price
$201
Updated
2024/03/01
More
Less

LOXIGLUMIDE Chemical Properties,Usage,Production

Uses

Loxiglumide is a CCK1 antagonist. Suppresses CCK-induced proliferation of acinar cells. Inhibits pancreatic secretion of digestive enzymes. Active in vivo.

Definition

ChEBI: Loxiglumide is an organic molecular entity.

Biochem/physiol Actions

Loxiglumide is a small-molecule antagonist of the cholecystokinin receptor CCKA. Loxiglumide inhibits pancreatic secretion of digestive enzymes, and also blocks CCK-induced gastric secretions and emptying.

Safety Profile

A poison by intravenous. Moderately toxic by ingestion, intraperitoneal, and subcutaneous routes. When heated to decomposition it emits toxic vapors of NOx and Cl-.

storage

Store at -20°C

LOXIGLUMIDE Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

LOXIGLUMIDE Suppliers

Shanghai Boyle Chemical Co., Ltd.
Tel
Fax
86-21-57758967
Email
sales@boylechem.com
Country
China
ProdList
2922
Advantage
55
LGM Pharma
Tel
1-(800)-881-8210
Fax
615-250-9817
Email
inquiries@lgmpharma.com
Country
United States
ProdList
2123
Advantage
70
Hangzhou Yuhao Chemical Technology Co., Ltd
Tel
0571-82693216
Fax
+86-571-82880190
Email
info@yuhaochemical.com
Country
China
ProdList
9387
Advantage
52
Shanghai Sphchem Co., Ltd.
Tel
21-21-56491756 13512199871
Fax
021-5649-1756
Email
sales@panhongchem.com
Country
China
ProdList
4000
Advantage
55
AdooQ BioScience, LLC
Tel
+1 (866) 930-6790
Fax
+1 (866) 333-9607
Email
info@adooq.com
Country
United States
ProdList
2782
Advantage
58
Shanghai JiYi Biotechnology Co. Ltd.
Tel
13621943973
Fax
-
Email
sales@shjiyipharmatech.com
Country
China
ProdList
1166
Advantage
55
Sigma-Aldrich
Tel
021-61415566 800-8193336
Email
orderCN@merckgroup.com
Country
China
ProdList
51456
Advantage
80
Guangzhou Zhiya Chemdrugs Co.,Ltd
Tel
18122150900
Fax
QQ:2869377561
Email
sculk28@163.com
Country
China
ProdList
646
Advantage
55
Shanghai Synchem Pharma Co., ltd
Tel
21-619849051-1 18521059765
Email
synchempharma@aliyun.com
Country
China
ProdList
6463
Advantage
55
Target molecule Corp.
Tel
857-239-0968
Fax
857-239-8801
Email
service1@targetmol.com
Country
United States
ProdList
2559
Advantage
60

107097-80-3, LOXIGLUMIDERelated Search:


  • 4-[(3,4-dichlorobenzoyl)amino]-5-[3-methoxypropyl(pentyl)amino]-5-oxopentanoic acid
  • 4-[(3,4-dichlorophenyl)carbonylamino]-5-[3-methoxypropyl(pentyl)amino]-5-oxo-pentanoic acid
  • 5-[amyl(3-methoxypropyl)amino]-4-[(3,4-dichlorobenzoyl)amino]-5-keto-valeric acid
  • LoxigluMide (CR1505)
  • LOXIGLUMIDE
  • CS-162
  • Loxiglumide, >98%
  • (+-)-4-((3,4-dichlorobenzoyl)amino)-5-((3-methoxypropyl)pentylamino)-5-oxope
  • (+-)--5-oxo
  • anoicacid
  • cr1505
  • d,l-4-(3,4-dichlorobenzoylamino)-5-(n-3-methoxypropylpentylamino)-5-oxo-pent
  • ntanoicacid
  • pentanoicacid,4-((3,4-dichlorobenzoyl)amino)-5-((3-methoxypropyl)pentylamino)
  • Pentanoic acid, 4-[(3,4-dichlorobenzoyl)amino]-5-[(3-methoxypropyl)pentylamino]-5-oxo-
  • Loxiglumide >=97% (HPLC)
  • CR1505,CR 1505,CCK Receptor,Inhibitor,Loxiglumide,inhibit,Cholecystokinin Receptor
  • 4-(3,4-Dichlorobenzamido)-5-((3-methoxypropyl)(pentyl)amino)-5-oxopentanoicacid
  • 4-[(3,4-dichlorophenyl)formamido]-4-[(3-methoxypropyl)(pentyl)carbamoyl]butanoic acid
  • 107097-80-3
  • C21H30Cl2N2O5
  • Inhibitors